Sumitomo Pharma Co., Ltd.

Financial

[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Dec'25 - QoQ",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "QoQ Growth in quarter ended Dec 2025 is 1.26% vs 10.29% in Sep 2025",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "QoQ Growth in quarter ended Dec 2025 is -89.94% vs 682.21% in Sep 2025",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Dec'25",
        "Sep'25",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "120,624.00",
          "val2": "119,120.00",
          "chgp": "1.26%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "17,220.00",
          "val2": "28,556.00",
          "chgp": "-39.70%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "5,138.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "8,817.00",
          "val2": "87,654.00",
          "chgp": "-89.94%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "98.70%",
          "val2": "195.40%",
          "chgp": "-9.67%",
          "chgp_class": "negative"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Mar'25",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Mar 2025 is 26.79% vs -43.38% in Mar 2024",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Mar 2025 is 107.50% vs -225.63% in Mar 2024",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Mar'25",
        "Mar'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "398,832.00",
          "val2": "314,558.00",
          "chgp": "26.79%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "47,984.00",
          "val2": "36,290.00",
          "chgp": "32.22%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "8,558.00",
          "val2": "4,277.00",
          "chgp": "100.09%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "-7,497.00",
          "val2": "-352,719.00",
          "chgp": "97.87%",
          "chgp_class": "positive"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "23,635.00",
          "val2": "-314,929.00",
          "chgp": "107.50%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "56.20%",
          "val2": "-4.70%",
          "chgp": "6.09%",
          "chgp_class": "positive"
        }
      ]
    }
  }
]

Quarterly Results Snapshot (Consolidated) - Dec'25 - QoQ

Dec'25

Sep'25

Change(%)

Net Sales

120,624.00

119,120.00

1.26%

Operating Profit (PBDIT) excl Other Income

17,220.00

28,556.00

-39.70%

Interest

5,138.00

0.00

Exceptional Items

0.00

0.00

Consolidate Net Profit

8,817.00

87,654.00

-89.94%

Operating Profit Margin (Excl OI)

98.70%

195.40%

-9.67%

USD in Million.

Compare with Peers

Net Sales

QoQ Growth in quarter ended Dec 2025 is 1.26% vs 10.29% in Sep 2025

Consolidated Net Profit

QoQ Growth in quarter ended Dec 2025 is -89.94% vs 682.21% in Sep 2025

All Quarterly Results

Annual Results Snapshot (Consolidated) - Mar'25

Mar'25

Mar'24

Change(%)

Net Sales

398,832.00

314,558.00

26.79%

Operating Profit (PBDIT) excl Other Income

47,984.00

36,290.00

32.22%

Interest

8,558.00

4,277.00

100.09%

Exceptional Items

-7,497.00

-352,719.00

97.87%

Consolidate Net Profit

23,635.00

-314,929.00

107.50%

Operating Profit Margin (Excl OI)

56.20%

-4.70%

6.09%

USD in Million.

Compare with Peers

Net Sales

YoY Growth in year ended Mar 2025 is 26.79% vs -43.38% in Mar 2024

Consolidated Net Profit

YoY Growth in year ended Mar 2025 is 107.50% vs -225.63% in Mar 2024

All Annual Results